136 related articles for article (PubMed ID: 22890959)
1. Sustainable synthesis and automated deposition: an accessible discovery screening library of fragment-like purines.
Kamper C; Korpis K; Specker E; Anger L; Neuenschwander M; Bednarski PJ; Link A
Mol Divers; 2012 Aug; 16(3):541-51. PubMed ID: 22890959
[TBL] [Abstract][Full Text] [Related]
2. Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549.
Bistrović A; Grbčić P; Harej A; Sedić M; Kraljević-Pavelić S; Koštrun S; Plavec J; Makuc D; Raić-Malić S
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):271-285. PubMed ID: 29271659
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3.
Wang X; He Q; Wu K; Guo T; Du X; Zhang H; Fang L; Zheng N; Zhang Q; Ye F
Eur J Med Chem; 2019 Oct; 179():218-232. PubMed ID: 31254923
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of 6-phenylaminopurines.
Canela MD; Liekens S; Camarasa MJ; Priego EM; Pérez-Pérez MJ
Eur J Med Chem; 2014 Nov; 87():421-8. PubMed ID: 25282265
[TBL] [Abstract][Full Text] [Related]
5. Lead optimization and biological evaluation of fragment-based cN-II inhibitors.
Guillon R; Rahimova R; Preeti ; Egron D; Rouanet S; Dumontet C; Aghajari N; Jordheim LP; Chaloin L; Peyrottes S
Eur J Med Chem; 2019 Apr; 168():28-44. PubMed ID: 30798051
[TBL] [Abstract][Full Text] [Related]
6. Lignopurines: a new family of hybrids between cyclolignans and purines. Synthesis and biological evaluation.
Castro MÁ; Miguel del Corral JM; García PA; Rojo MV; Bento AC; Mollinedo F; Francesch AM; San Feliciano A
Eur J Med Chem; 2012 Dec; 58():377-89. PubMed ID: 23153810
[TBL] [Abstract][Full Text] [Related]
7. Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays.
O Salas C; Zarate AM; Kryštof V; Mella J; Faundez M; Brea J; Loza MI; Brito I; Hendrychová D; Jorda R; Cabrera AR; Tapia RA; Espinosa-Bustos C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881717
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and docking studies of 4-amino-tetrahydroquinazolino[3,2-e]purine derivatives.
Verones V; Flouquet N; Farce A; Carato P; Leonce S; Pfeiffer B; Berthelot P; Lebegue N
Eur J Med Chem; 2010 Dec; 45(12):5678-84. PubMed ID: 20884092
[TBL] [Abstract][Full Text] [Related]
10. Improving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries.
Liu Y; Li F; Wu L; Wang W; Zhu H; Zhang Q; Zhou H; Yan B
Bioorg Med Chem Lett; 2015 May; 25(9):1971-5. PubMed ID: 25827524
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and in vitro anti-tumor activities of novel 9-ethyl-9H-purine derivatives.
Ningegowda R; Grover A; Basappa ; Ranjith S; Rangappa KS; Priya BS; Nanjunda Swamy S
Invest New Drugs; 2010 Dec; 28(6):754-65. PubMed ID: 19756377
[TBL] [Abstract][Full Text] [Related]
12. A facile hybrid 'flow and batch' access to substituted 3,4-dihydro-2H-benzo[b][1,4]oxazinones.
Lin AJ; Russell CC; Baker JR; Frailey SL; Sakoff JA; McCluskey A
Org Biomol Chem; 2016 Sep; 14(37):8732-8742. PubMed ID: 27714138
[TBL] [Abstract][Full Text] [Related]
13. Hsp90 inhibitors and drugs from fragment and virtual screening.
Roughley S; Wright L; Brough P; Massey A; Hubbard RE
Top Curr Chem; 2012; 317():61-82. PubMed ID: 21647838
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel substituted purine derivatives and identification of the cell death mechanism.
Demir Z; Guven EB; Ozbey S; Kazak C; Atalay RC; Tuncbilek M
Eur J Med Chem; 2015 Jan; 89():701-20. PubMed ID: 25462277
[TBL] [Abstract][Full Text] [Related]
15. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
Kim J; Kim H; Park SB
J Am Chem Soc; 2014 Oct; 136(42):14629-38. PubMed ID: 25310802
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
Khaybullin RN; Liang X; Cisneros K; Qi X
Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.
Conejo-García A; García-Rubiño ME; Marchal JA; Núñez MC; Ramírez A; Cimino S; García MÁ; Aránega A; Gallo MA; Campos JM
Eur J Med Chem; 2011 Sep; 46(9):3795-801. PubMed ID: 21645946
[TBL] [Abstract][Full Text] [Related]
18. Novel pyrimidine and purine derivatives of L-ascorbic acid: synthesis and biological evaluation.
Raić-Malić S; Hergold-Brundić A; Nagl A; Grdisa M; Pavelić K; De Clercq E; Mintas M
J Med Chem; 1999 Jul; 42(14):2673-8. PubMed ID: 10411487
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacophore modelling of 2,6,9-trisubstituted purine derivatives and their potential role as apoptosis-inducing agents in cancer cell lines.
Calderón-Arancibia J; Espinosa-Bustos C; Cañete-Molina Á; Tapia RA; Faúndez M; Torres MJ; Aguirre A; Paulino M; Salas CO
Molecules; 2015 Apr; 20(4):6808-26. PubMed ID: 25884555
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and quarternization of 6-(substitutedamino)-purines with antitumor activity screening.
el-Bayouki KA; Basyouni WM; el-Din SM; Habeeb AG
Arch Pharm Res; 1994 Apr; 17(2):60-5. PubMed ID: 10319132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
